Table 1:

Clinical and echocardiographic preoperative data in the ‘MitraClip’ and ‘Surgical edge-to-edge’ groups

MitraClip group
n = 85
Surgical EE group
n = 58
P -value
Male gender ( n , %) 70 (82)40 (69)0.06
Age (years)69 ± 9.462 ± 10.10.0001
Ischaemic DCM ( n , %) 62 (73)36 (62)0.1
NYHA class ( n , %) 0.9
 II13 (15)9 (15)
 III57 (67)36 (62)
 IV15 (17)13 (22)
Atrial fibrillation ( n , %) 24 (28)12 (20)0.3
Log EuroSCORE19 ± 15.911.4 ± 3.20.04
LVEF (%)28 ± 9.728 ± 6.50.4
LVEDD (mm)67 ± 7.869 ± 5.80.1
LVESD (mm)54 ± 9.152 ± 7.90.3
LVEDV (ml)188 ± 66.2203 ± 58.020.1
SPAP (mmHg)47 ± 14.248 ± 13.20.5
SPAP > 40 mmHg ( n , %) 46 (54)33 (56)0.1
TR 3+ or 4+ ( n , %) 17 (20)11 (19)0.8
Coaptation depth (cm)1.2 ± 0.341.2 ± 0.460.5
Tented area (cm 2 ) 2.8 ± 0.992.8 ± 0.880.6
MitraClip group
n = 85
Surgical EE group
n = 58
P -value
Male gender ( n , %) 70 (82)40 (69)0.06
Age (years)69 ± 9.462 ± 10.10.0001
Ischaemic DCM ( n , %) 62 (73)36 (62)0.1
NYHA class ( n , %) 0.9
 II13 (15)9 (15)
 III57 (67)36 (62)
 IV15 (17)13 (22)
Atrial fibrillation ( n , %) 24 (28)12 (20)0.3
Log EuroSCORE19 ± 15.911.4 ± 3.20.04
LVEF (%)28 ± 9.728 ± 6.50.4
LVEDD (mm)67 ± 7.869 ± 5.80.1
LVESD (mm)54 ± 9.152 ± 7.90.3
LVEDV (ml)188 ± 66.2203 ± 58.020.1
SPAP (mmHg)47 ± 14.248 ± 13.20.5
SPAP > 40 mmHg ( n , %) 46 (54)33 (56)0.1
TR 3+ or 4+ ( n , %) 17 (20)11 (19)0.8
Coaptation depth (cm)1.2 ± 0.341.2 ± 0.460.5
Tented area (cm 2 ) 2.8 ± 0.992.8 ± 0.880.6

LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEDV: left ventricular end-diastolic volume; SPAP: systolic pulmonary artery pressure; TR: tricuspid regurgitation; EE: edge-to-edge; NYHA: New York Heart Association; DCM: dilated cardiomyopathy.

Table 1:

Clinical and echocardiographic preoperative data in the ‘MitraClip’ and ‘Surgical edge-to-edge’ groups

MitraClip group
n = 85
Surgical EE group
n = 58
P -value
Male gender ( n , %) 70 (82)40 (69)0.06
Age (years)69 ± 9.462 ± 10.10.0001
Ischaemic DCM ( n , %) 62 (73)36 (62)0.1
NYHA class ( n , %) 0.9
 II13 (15)9 (15)
 III57 (67)36 (62)
 IV15 (17)13 (22)
Atrial fibrillation ( n , %) 24 (28)12 (20)0.3
Log EuroSCORE19 ± 15.911.4 ± 3.20.04
LVEF (%)28 ± 9.728 ± 6.50.4
LVEDD (mm)67 ± 7.869 ± 5.80.1
LVESD (mm)54 ± 9.152 ± 7.90.3
LVEDV (ml)188 ± 66.2203 ± 58.020.1
SPAP (mmHg)47 ± 14.248 ± 13.20.5
SPAP > 40 mmHg ( n , %) 46 (54)33 (56)0.1
TR 3+ or 4+ ( n , %) 17 (20)11 (19)0.8
Coaptation depth (cm)1.2 ± 0.341.2 ± 0.460.5
Tented area (cm 2 ) 2.8 ± 0.992.8 ± 0.880.6
MitraClip group
n = 85
Surgical EE group
n = 58
P -value
Male gender ( n , %) 70 (82)40 (69)0.06
Age (years)69 ± 9.462 ± 10.10.0001
Ischaemic DCM ( n , %) 62 (73)36 (62)0.1
NYHA class ( n , %) 0.9
 II13 (15)9 (15)
 III57 (67)36 (62)
 IV15 (17)13 (22)
Atrial fibrillation ( n , %) 24 (28)12 (20)0.3
Log EuroSCORE19 ± 15.911.4 ± 3.20.04
LVEF (%)28 ± 9.728 ± 6.50.4
LVEDD (mm)67 ± 7.869 ± 5.80.1
LVESD (mm)54 ± 9.152 ± 7.90.3
LVEDV (ml)188 ± 66.2203 ± 58.020.1
SPAP (mmHg)47 ± 14.248 ± 13.20.5
SPAP > 40 mmHg ( n , %) 46 (54)33 (56)0.1
TR 3+ or 4+ ( n , %) 17 (20)11 (19)0.8
Coaptation depth (cm)1.2 ± 0.341.2 ± 0.460.5
Tented area (cm 2 ) 2.8 ± 0.992.8 ± 0.880.6

LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEDV: left ventricular end-diastolic volume; SPAP: systolic pulmonary artery pressure; TR: tricuspid regurgitation; EE: edge-to-edge; NYHA: New York Heart Association; DCM: dilated cardiomyopathy.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close